Taiwan draws foreign biotech IPOs


Vibrant scene: Taiwan is home to the largest number of listed biotechnology companies in Asia with the sector expanding due to a well-educated workforce, historic appetite for high-tech industries and government support. – AFP

Singapore firm working on experimental cancer drugs plans listing by end-May

HONG KONG: A Singaporean biotechnology company working on experimental cancer drugs is listing in Taiwan, potentially opening the door for more foreign peers to go public on the island.

Get 30% off with our ads free Premium Plan!

Monthly Plan

RM13.90/month
RM9.73 only

Billed as RM9.73 for the 1st month then RM13.90 thereafters.

Annual Plan

RM12.33/month
RM8.63/month

Billed as RM103.60 for the 1st year then RM148 thereafters.

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!

Business , IPO , cancer , drugs , Taiwan

   

Next In Business News

Tuju Setia’s order book hits RM2bil with RM389mil Milla Residence contract
FBM KLCI edges higher at midday, banking stocks lead
Airbus, Rolls-Royce step in to resolve Malaysia Airlines' grounded A330neo
Jeff Bezos says most people should take more risks. Here’s the science that proves he’s right
Brace! Risks stack up for the global economy in 2025
Malaysia continues to lead regional data centre index
IFC, consortium commit over US$900mil in financing to data centre in Malaysia
Foreign investors offload RM1.07bil on Bursa Malaysia for ninth week running
Bursa Malaysia confirms CEO succession process amid speculation
KLCC Property denies Bandar Malaysia takeover

Others Also Read